1h Free Analyst Time
The publisher has been monitoring the molecular biology enzymes, kits, and reagents market and it is poised to grow by $13.09 bn during 2021-2025, progressing at a CAGR of 14.61% during the forecast period. The report on the molecular biology enzymes, kits, and reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased use of proteins and reagents in biotechnology and pharmaceutical companies and rising incidence of infectious diseases and genetic disorders.
The molecular biology enzymes, kits, and reagents market analysis includes the end-user segment and geographic landscape.
The molecular biology enzymes, kits, and reagents market is segmented as below:
By End-user
- Biotechnology and pharmaceutical companies
- Hospitals and diagnostic centers
- Academic institutes and research organizations
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the rising number of genome projects as one of the prime reasons driving the molecular biology enzymes, kits, and reagents market growth during the next few years.
The report on molecular biology enzymes, kits, and reagents market covers the following areas:
- Molecular biology enzymes, kits, and reagents market sizing
- Molecular biology enzymes, kits, and reagents market forecast
- Molecular biology enzymes, kits, and reagents market industry analysis
The publisher robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading molecular biology enzymes, kits, and reagents market vendors that include Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. Also, the molecular biology enzymes, kits, and reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025
- Hospitals and diagnostic centers - Market size and forecast 2020-2025
- Academic institutes and research organizations - Market size and forecast 2020-2025
- Market opportunity by End-user
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Agilent Technologies Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Merck KGaA
- New England Biolabs Inc.
- Promega Corp.
- QIAGEN NV
- Rockland Immunochemicals Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Exhibits 1: Key Finding 1
- Exhibits 2: Key Finding 2
- Exhibits 3: Key Finding 3
- Exhibits 4: Key Finding 5
- Exhibits 5: Key Finding 6
- Exhibits 6: Key Finding 7
- Exhibits 7: Key Finding 8
- Exhibits 8: Parent market
- Exhibits 9: Market characteristics
- Exhibits 10: Offerings of vendors included in the market definition
- Exhibits 11: Market segments
- Exhibits 12: Global - Market size and forecast 2020 - 2025 ($ million)
- Exhibits 13: Global market: Year-over-year growth 2020 - 2025 (%)
- Exhibits 14: Five forces analysis 2020 & 2025
- Exhibits 15: Bargaining power of buyers
- Exhibits 16: Bargaining power of suppliers
- Exhibits 17: Threat of new entrants
- Exhibits 18: Threat of substitutes
- Exhibits 19: Threat of rivalry
- Exhibits 20: Market condition - Five forces 2020
- Exhibits 21: End-user - Market share 2020-2025 (%)
- Exhibits 22: Comparison by End-user
- Exhibits 23: Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025 ($ million)
- Exhibits 24: Biotechnology and pharmaceutical companies - Year-over-year growth 2020-2025 (%)
- Exhibits 25: Hospitals and diagnostic centers - Market size and forecast 2020-2025 ($ million)
- Exhibits 26: Hospitals and diagnostic centers - Year-over-year growth 2020-2025 (%)
- Exhibits 27: Academic institutes and research organizations - Market size and forecast 2020-2025 ($ million)
- Exhibits 28: Academic institutes and research organizations - Year-over-year growth 2020-2025 (%)
- Exhibits 29: Market opportunity by End-user
- Exhibits 30: Customer landscape
- Exhibits 31: Market share By Geographical Landscape 2020-2025 (%)
- Exhibits 32: Geographic comparison
- Exhibits 33: North America - Market size and forecast 2020-2025 ($ million)
- Exhibits 34: North America - Year-over-year growth 2020-2025 (%)
- Exhibits 35: Europe - Market size and forecast 2020-2025 ($ million)
- Exhibits 36: Europe - Year-over-year growth 2020-2025 (%)
- Exhibits 37: Asia - Market size and forecast 2020-2025 ($ million)
- Exhibits 38: Asia - Year-over-year growth 2020-2025 (%)
- Exhibits 39: ROW - Market size and forecast 2020-2025 ($ million)
- Exhibits 40: ROW - Year-over-year growth 2020-2025 (%)
- Exhibits 41: Key leading countries
- Exhibits 42: Market opportunity By Geographical Landscape ($ million)
- Exhibits 43: Impact of drivers and challenges
- Exhibits 44: Vendor landscape
- Exhibits 45: Landscape disruption
- Exhibits 46: Industry risks
- Exhibits 47: Vendors covered
- Exhibits 48: Market positioning of vendors
- Exhibits 49: Agilent Technologies Inc. - Overview
- Exhibits 50: Agilent Technologies Inc. - Business segments
- Exhibits 51: Agilent Technologies Inc. - Key offerings
- Exhibits 52: Agilent Technologies Inc. - Key customers
- Exhibits 53: Agilent Technologies Inc. - Segment focus
- Exhibits 54: F. Hoffmann-La Roche Ltd. - Overview
- Exhibits 55: F. Hoffmann-La Roche Ltd. - Business segments
- Exhibits 56: F. Hoffmann-La Roche Ltd. - Key offerings
- Exhibits 57: F. Hoffmann-La Roche Ltd. - Key customers
- Exhibits 58: F. Hoffmann-La Roche Ltd. - Segment focus
- Exhibits 59: Illumina Inc. - Overview
- Exhibits 60: Illumina Inc. - Product and service
- Exhibits 61: Illumina Inc. - Key offerings
- Exhibits 62: Illumina Inc. - Key customers
- Exhibits 63: Illumina Inc. - Segment focus
- Exhibits 64: Merck KGaA - Overview
- Exhibits 65: Merck KGaA - Business segments
- Exhibits 66: Merck KGaA - Key offerings
- Exhibits 67: Merck KGaA - Key customers
- Exhibits 68: Merck KGaA - Segment focus
- Exhibits 69: New England Biolabs Inc. - Overview
- Exhibits 70: New England Biolabs Inc. - Product and service
- Exhibits 71: New England Biolabs Inc. - Key offerings
- Exhibits 72: New England Biolabs Inc. - Key customers
- Exhibits 73: New England Biolabs Inc. - Segment focus
- Exhibits 74: Promega Corp. - Overview
- Exhibits 75: Promega Corp. - Product and service
- Exhibits 76: Promega Corp. - Key offerings
- Exhibits 77: Promega Corp. - Key customers
- Exhibits 78: Promega Corp. - Segment focus
- Exhibits 79: QIAGEN NV - Overview
- Exhibits 80: QIAGEN NV - Business segments
- Exhibits 81: QIAGEN NV - Key offerings
- Exhibits 82: QIAGEN NV - Key customers
- Exhibits 83: QIAGEN NV - Segment focus
- Exhibits 84: Rockland Immunochemicals Inc.- Overview
- Exhibits 85: Rockland Immunochemicals Inc.- Product and service
- Exhibits 86: Rockland Immunochemicals Inc.- Key offerings
- Exhibits 87: Rockland Immunochemicals Inc.- Key customers
- Exhibits 88: Rockland Immunochemicals Inc.- Segment focus
- Exhibits 89: Takara Bio Inc. - Overview
- Exhibits 90: Takara Bio Inc. - Business segments
- Exhibits 91: Takara Bio Inc. - Key offerings
- Exhibits 92: Takara Bio Inc. - Key customers
- Exhibits 93: Takara Bio Inc. - Segment focus
- Exhibits 94: Thermo Fisher Scientific Inc. - Overview
- Exhibits 95: Thermo Fisher Scientific Inc. - Business segments
- Exhibits 96: Thermo Fisher Scientific Inc. - Key offerings
- Exhibits 97: Thermo Fisher Scientific Inc. - Key customers
- Exhibits 98: Thermo Fisher Scientific Inc. - Segment focus
- Exhibits 99: Currency conversion rates for US$
- Exhibits 100: Research Methodology
- Exhibits 101: Validation techniques employed for market sizing
- Exhibits 102: Information sources
- Exhibits 103: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global molecular biology enzymes, kits, and reagents market: Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rising number of genome projects.`
According to the report, one of the major drivers for this market is the increased use of proteins and reagents in biotechnology and pharmaceutical companies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Merck KGaA
- New England Biolabs Inc.
- Promega Corp.
- QIAGEN NV
- Rockland Immunochemicals Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
